US Patent 9803016 Anti-CD47 antibodies and methods of use
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+207 characters)
Article
Patent abstract
Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09803016 Anti-CD47 antibodies and methods of use US Patent 9803016 Anti-CD47 antibodies and methods of use
Infobox
Patent Number
0980301600
Patent Number
980301600
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
098030160
Date of Patent
October 31, 2017
0Patent Application Number
154732060
Date Filed
March 29, 2017
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
098030160
Date of Patent
October 31, 2017
0Patent Application Number
154732060
Date Filed
March 29, 2017
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09803016 Anti-CD47 antibodies and methods of use
Infobox
Is a
Patent jurisdiction
Patent number
09803016
Date of patent
October 31, 2017
Patent application number
15473206
Date Filed
March 29, 2017
Patent primary examiner
Find more entities like US Patent 9803016 Anti-CD47 antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.